Cargando…

Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence

Background. Cryptococcal meningitis has a high mortality in human immunodeficiency virus (HIV)-infected persons in Africa. This is preventable with early screening and preemptive therapy. We evaluated the prevalence of cryptococcal disease by antigen testing, possible associated factors, and outcome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oladele, Rita O., Akanmu, Alani S., Nwosu, Augustina O., Ogunsola, Folasade T., Richardson, Malcolm D., Denning, David W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866571/ https://www.ncbi.nlm.nih.gov/pubmed/27186581 http://dx.doi.org/10.1093/ofid/ofw055

Ejemplares similares

Opportunistic fungal infections in persons living with advanced HIV disease in Lagos, Nigeria; a 12-year retrospective study
por: Oladele, Rita, et al.
Publicado: (2020)

Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality
por: Letang, Emilio, et al.
Publicado: (2015)

Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy–Experienced Ugandans With Virologic Failure
por: Mpoza, Edward, et al.
Publicado: (2019)

Antibody Responses in HIV-Infected Patients With Advanced Immunosuppression and Asymptomatic Cryptococcal Antigenemia
por: Hlupeni, Admire, et al.
Publicado: (2018)

A multicenter survey of asymptomatic cryptococcal antigenemia among patients with advanced HIV disease in Nigeria
por: Oladele, Rita O., et al.
Publicado: (2023)

Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications
por: Wake, Rachel M, et al.
Publicado: (2022)

High Burden of Cryptococcal Meningitis Among Antiretroviral Therapy–Experienced Human Immunodeficiency Virus–Infected Patients in Northern Uganda in the Era of “Test and Treat”: Implications for Cryptococcal Screening Programs
por: Okwir, Mark, et al.
Publicado: (2022)

375. Cryptococcal Antigenemia in Advanced HIV Infection
por: Ahuja, Jatin, et al.
Publicado: (2019)

Standardization of Aspergillus IgG diagnostic cutoff in Nigerians
por: Oladele, Rita O., et al.
Publicado: (2021)

Comparison of Cryptococcal Antigenemia between Antiretroviral Naïve and Antiretroviral Experienced HIV Positive Patients at Two Hospitals in Ethiopia
por: Beyene, Tafese, et al.
Publicado: (2013)

High Prevalence of Cryptococcal Antigenemia among HIV-infected Patients Receiving Antiretroviral Therapy in Ethiopia
por: Alemu, Abere Shiferaw, et al.
Publicado: (2013)

Cryptococcal and Histoplasma Antigen Screening Among People With Human Immunodeficiency Virus in Ghana and Comparative Analysis of OIDx Histoplasma Lateral Flow Assay and IMMY Histoplasma Enzyme Immunoassay
por: Ocansey, Bright K, et al.
Publicado: (2022)

Tackling cryptococcal meningitis in Nigeria, one-step at a time; the impact of training
por: Oladele, Rita O., et al.
Publicado: (2020)

Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and Outcomes
por: Pastick, Katelyn A, et al.
Publicado: (2019)

Prevalence of Cryptococcal Antigenemia and Cost-Effectiveness of a Cryptococcal Antigen Screening Program – Vietnam
por: Smith, Rachel M., et al.
Publicado: (2013)

Income Inequality Is Associated With Low Cumulative Antiretroviral Adherence in Persons With Human Immunodeficiency Virus
por: Vernon, Frances, et al.
Publicado: (2020)

Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis
por: De Castro, Nathalie, et al.
Publicado: (2022)

Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study
por: Ingle, Suzanne M, et al.
Publicado: (2023)

Prevalence of Cryptococcal Antigen and Outcomes in People With Human Immunodeficiency Virus in Honduras: A Cohort Study
por: Zuniga-Moya, Julio C, et al.
Publicado: (2020)

Hyponatremia as a Predictor of Cryptococcal Meningitis and Death Among Asymptomatic Persons With HIV and Cryptococcal Antigenemia
por: Lehman, Alice, et al.
Publicado: (2023)

Acute Kidney Injury and Urinary Biomarkers in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis
por: Schutz, Charlotte, et al.
Publicado: (2017)

Prevalence and Factors Associated With Cryptoccocal Antigenemia Among Patients With Advanced Human Immunodeficiency Virus in Eastern Uganda: A Facility-Based Cross-sectional Study
por: Eric, Ebonu, et al.
Publicado: (2023)

Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection( )
por: Verkerke, Hans P, et al.
Publicado: (2022)

No Association of Cryptococcal Antigenemia with Poor Outcomes among Antiretroviral Therapy-Experienced HIV-Infected Patients in Addis Ababa, Ethiopia
por: Smitson, Christopher C., et al.
Publicado: (2014)

Underlying Cryptococcal Diseases and the Correlation With Serum Cryptococcal Antigen Titers in Hospitalized HIV-Infected Patients Screened Positive for Cryptococcal Antigenemia
por: Xu, Miaomiao, et al.
Publicado: (2020)

The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment
por: Kamal, Susan, et al.
Publicado: (2017)

Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2023)

Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence Barriers
por: Chen, Wanyi, et al.
Publicado: (2023)

Screening for cryptococcal antigenemia using the lateral flow assay in antiretroviral therapy-naïve HIV-positive adults at an Ethiopian hospital clinic
por: Reepalu, Anton, et al.
Publicado: (2015)

Cryptococcal meningitis after ART: Need for proper baseline evaluation in the era of ‘Test & Treat’
por: Akase, Iorhen E., et al.
Publicado: (2019)

Prevalence of HIV related oral lesions in people living with HIV and on combined antiretroviral therapy: a Nigerian experience
por: Mary, Eweka Olutola, et al.
Publicado: (2018)

Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia
por: Ganiem, Ahmad Rizal, et al.
Publicado: (2014)

Increased mortality among HIV infected patients with cryptococcal antigenemia in Guinea-Bissau
por: Thomsen, Ditte, et al.
Publicado: (2018)

Opportunistic Cryptococcal Antigenemia in the HAART Era at HIV Epidemic Settings of Northwest Ethiopia
por: Negash, Markos, et al.
Publicado: (2020)

Asymptomatic cryptococcal antigenemia in HIV-infected patients: a review of recent studies
por: Xu, Xiao-Lei, et al.
Publicado: (2020)

Comparative Effectiveness of Induction Therapy for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: A Network Meta-Analysis
por: Campbell, Jeffrey I., et al.
Publicado: (2015)

Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?
por: Kagimu, Enock, et al.
Publicado: (2022)

Cryptococcal Antigen Screening Among Antiretroviral Therapy–Experienced People With HIV With Viral Load Nonsuppression in Rural Uganda
por: Baluku, Joseph Baruch, et al.
Publicado: (2021)

HIV-Associated Cryptococcal Disease in Resource-Limited Settings: A Case for “Prevention Is Better Than Cure”?
por: Oladele, Rita O., et al.
Publicado: (2017)

Prior Pulmonary Tuberculosis Is a Risk Factor for Asymptomatic Cryptococcal Antigenemia in a Cohort of Adults With Advanced Human Immunodeficiency Virus Disease
por: Wake, Rachel M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r9uojiu3mlb9rc815u8vt8aauu